Towercrest Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Towercrest Capital Management's PFE Position: Q3 2026 in Review
Towercrest Capital Management held its Pfizer (PFE) position steady in Q3 2026 at 10,599 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #84.
Towercrest Capital Management first reported a position in PFE in Q3 2018 and has held it in 28 quarters since. The position peaked at $437K in Q3 2024. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Towercrest Capital Management held 10,599 shares of Pfizer worth $302K as of Q3 2026.
- Towercrest Capital Management left its Pfizer share count unchanged in Q3 2026.
- Pfizer made up 0.04% of Towercrest Capital Management's portfolio in Q3 2026, its #84 holding.
- Towercrest Capital Management first reported a position in Pfizer in Q3 2018 and has held it in 28 quarters since.
- Towercrest Capital Management's Pfizer position peaked at $437K in Q3 2024.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Towercrest Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.